K. Asnong

A pilot study on the use of the humanized anti-interleukin-2 receptor antibody daclizumab in active ulcerative colitis.

P. Rutgeerts, M. Noman, I. Aerden, 2003 .

A Pilot Study on the Use of the Humanized Anti–Interleukin-2 Receptor Antibody Daclizumab in Active Ulcerative Colitis

P. Rutgeerts, M. Noman, I. Aerden, 2003, American Journal of Gastroenterology.

Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis.

P. Rutgeerts, S. Vermeire, G. D'Haens, 2003, Gastroenterology.

HIGH-DOSE VITAMIN D DOES NOT PREVENT POSTOPERATIVE RECURRENCE OF CROHN'S DISEASE IN A RANDOMIZED PLACEBO-CONTROLLED TRIAL.

C. Buskens, W. Bemelman, D. Franchimont, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Is also the patient ready for switching from intravenous to subcutaneous biologicals?

P. Bossuyt, L. Pouillon, K. Asnong, 2021, Journal of Crohn's & Colitis.